These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 27145460

  • 1. Significance of microRNA-related variants in susceptibility to recurrence of oropharyngeal cancer patients after definitive radiotherapy.
    Chen X, Sturgis EM, Wang C, Cao X, Li Y, Wei Q, Li G.
    Oncotarget; 2016 Jun 07; 7(23):35015-25. PubMed ID: 27145460
    [Abstract] [Full Text] [Related]

  • 2. Genetic variants in microRNA-binding sites of DNA repair genes as predictors of recurrence in patients with squamous cell carcinoma of the oropharynx.
    Zhu L, Sturgis EM, Zhang H, Lu Z, Tao Y, Wei Q, Li G.
    Int J Cancer; 2017 Oct 01; 141(7):1355-1364. PubMed ID: 28646528
    [Abstract] [Full Text] [Related]

  • 3. Modifying effect of mouse double minute-2 promoter variants on risk of recurrence for patients with squamous cell carcinoma of oropharynx.
    Zhang Y, Sturgis EM, Li Y, Wei Q, Huang Z, Li G.
    Sci Rep; 2017 Jan 03; 7():39765. PubMed ID: 28045062
    [Abstract] [Full Text] [Related]

  • 4. E2F transcription factor 2 variants as predictive biomarkers for recurrence risk in patients with squamous cell carcinoma of the oropharynx.
    Li Y, Sturgis EM, Zhu L, Cao X, Wei Q, Zhang H, Li G.
    Mol Carcinog; 2017 Apr 03; 56(4):1335-1343. PubMed ID: 27864908
    [Abstract] [Full Text] [Related]

  • 5. Mouse double minute 4 variants modify susceptibility to risk of recurrence in patients with squamous cell carcinoma of the oropharynx.
    Lu Z, Sturgis EM, Zhu L, Zhang H, Tao Y, Wei P, Wei Q, Li G.
    Mol Carcinog; 2018 Mar 03; 57(3):361-369. PubMed ID: 29073727
    [Abstract] [Full Text] [Related]

  • 6. Pre-microRNA variants predict HPV16-positive tumors and survival in patients with squamous cell carcinoma of the oropharynx.
    Guan X, Sturgis EM, Song X, Liu Z, El-Naggar AK, Wei Q, Li G.
    Cancer Lett; 2013 Apr 28; 330(2):233-40. PubMed ID: 23219900
    [Abstract] [Full Text] [Related]

  • 7. Apoptotic variants as predictors of risk of oropharyngeal cancer recurrence after definitive radiotherapy.
    Zhang F, Sturgis EM, Sun Y, Zhang Y, Wei Q, Zhang C, Zheng H, Li G.
    Int J Cancer; 2015 Nov 15; 137(10):2454-61. PubMed ID: 25976983
    [Abstract] [Full Text] [Related]

  • 8. A functional variant at miRNA-122 binding site in IL-1a 3' UTR predicts risk of recurrence in patients with oropharyngeal cancer.
    Wang C, Sturgis EM, Chen X, Wei Q, Li G.
    Oncotarget; 2016 Jun 07; 7(23):34472-9. PubMed ID: 27121322
    [Abstract] [Full Text] [Related]

  • 9. Genetic variants in TNF-α promoter are predictors of recurrence in patients with squamous cell carcinoma of oropharynx after definitive radiotherapy.
    Zhang C, Sturgis EM, Zheng H, Song X, Wei P, Jin L, Chao L, Wei Q, Li G.
    Int J Cancer; 2014 Apr 15; 134(8):1907-15. PubMed ID: 24122460
    [Abstract] [Full Text] [Related]

  • 10. A genetic variant within MDM4 3'UTR miRNA binding site is associated with HPV16-positive tumors and survival of oropharyngeal cancer.
    Zhang Y, Sturgis EM, Wei P, Liu H, Wang Z, Ma Y, Liu C, Gu KJ, Wei Q, Li G.
    Mol Carcinog; 2019 Dec 15; 58(12):2276-2285. PubMed ID: 31513313
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pre-miRNA variants as predictors of clinical outcome in patients with squamous cell carcinomas of the nonoropharynx.
    Wang C, Sturgis EM, Chen X, Zheng H, Wei Q, Li G.
    Oncotarget; 2016 May 03; 7(18):26444-53. PubMed ID: 27050146
    [Abstract] [Full Text] [Related]

  • 13. Variants in nucleotide excision repair core genes and susceptibility to recurrence of squamous cell carcinoma of the oropharynx.
    Song X, Sturgis EM, Jin L, Wang Z, Wei Q, Li G.
    Int J Cancer; 2013 Aug 01; 133(3):695-704. PubMed ID: 23335232
    [Abstract] [Full Text] [Related]

  • 14. A functional variant at miRNA-122 binding site in IL-1α 3' UTR predicts risk and HPV-positive tumours of oropharyngeal cancer.
    Zhang Y, Sturgis EM, Sun Y, Sun C, Wei Q, Huang Z, Li G.
    Eur J Cancer; 2015 Jul 01; 51(11):1415-23. PubMed ID: 25981582
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A let-7 microRNA polymorphism in the KRAS 3'-UTR is prognostic in oropharyngeal cancer.
    De Ruyck K, Duprez F, Ferdinande L, Mbah C, Rios-Velazquez E, Hoebers F, Praet M, Deron P, Bonte K, Speel EJ, Libbrecht L, De Neve W, Lambin P, Thierens H.
    Cancer Epidemiol; 2014 Oct 01; 38(5):591-8. PubMed ID: 25127693
    [Abstract] [Full Text] [Related]

  • 19. Lymphocyte telomere length predicts clinical outcomes of HPV-positive oropharyngeal cancer patients after definitive radiotherapy.
    Luo X, Sturgis EM, Yang Z, Sun Y, Wei P, Liu Z, Wei Q, Li G.
    Carcinogenesis; 2019 Jul 06; 40(6):735-741. PubMed ID: 30721961
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-10 promoter variants predict HPV-positive tumors and survival of squamous cell carcinoma of the oropharynx.
    Jin L, Sturgis EM, Cao X, Song X, Salahuddin T, Wei Q, Li G.
    FASEB J; 2013 Jun 06; 27(6):2496-503. PubMed ID: 23430974
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.